Advanced search
Publication Cover
Journal of Medical Economics Volume 15, 2012 - Issue 2
Submit an article Journal homepage
2,523
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis

E. J. SoiniESiOR Oy KuopioFinlandCorrespondence[email protected]
,
T. A. HallinenESiOR Oy KuopioFinland
,
K. PuolakkaLappeenranta Central Hospital LappeenrantaFinland
,
V. VihervaaraRoche Oy EspooFinland
&
M. J. KauppiDepartment of Rheumatology, Päijät-Häme Central Hospital LahtiFinland
Pages 340-351 | Accepted 29 Nov 2011, Published online: 06 Jan 2012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.